PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
- Country
- Netherlands
- Type
- Beneficiary
- Website
- www.prinsesmaximacentrum.nl
- Grants received
- 39
Funding record
- 39 grants on record
- €38,593,683.16 awarded in total
- 2011–2027 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
- Horizon Europe Framework Programme
- European Research Council
- Seventh Framework Programme
- Horizon 2020 Framework Programme
12 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- OSPEDALE PEDIATRICO BAMBINO GESU
- ST. ANNA KINDERKREBSFORSCHUNG GMBH
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- INSTITUT GUSTAVE ROUSSY
- OSLO UNIVERSITETSSYKEHUS HF
- REGION HOVEDSTADEN
- SIOP EUROPE
- DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
Calls from this organisation
No published calls from this organisation.
Grants received
- Training program to engage flexible and disordered protein targets for therapeutic development: The oncogene β-catenin as showcase.
- Base editing against cancer – a gene correction strategy for rhabdoid tumours
- Decoding the dark proteome through interdisciplinary training and research
- immunoTHErapies targeting neOgenes in paeDiatric and adOlescent saRcomAs
- European Pediatric Immunotherapy Trial with Combinatory ATMPs for DIPG
- FROM POPULATIONS TO CELLS AND BACK: Carcinogen Unmasking and Effect characterization in early-onset
- CUTTING-EDGE HUMAN IN VITRO AND IN SILICO BIOMEDICAL TOOLS ON BRAIN DISORDERS
- Disentangling the relationship between autoimmunity, cancer treatment, and risk of subsequent breast cancer
- Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies
- Deciphering non-genetic determinants and targetability of cancer cell plasticity.
- Patient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer
- Instrument-free 3D molecular imaging with the VOLumetric UMI-Network EXplorer
- Centre of Excellence for Precision Medicine in Pediatric Care
- The GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementation
- Scaling up early and late effects research in Lithuanian childhood cancer survivors through education and twinning
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.